| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.096 | 0.03 |